Magdalena Plebanski

43PUBLICATIONS
113CO-AUTHORS
Biomolecular modelling and designMolecular targetsHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|May 27, 2026
(<i>E</i>)-4-(4-Acrylamidophenoxy)-<i>N</i>-Methylpicolinamides as b-Raf/VEGFR-2 Inhibitors with Antiangiogenic Activity in HUVEC and Zebrafish Model.

|Feb 27, 2026
Nature-Inspired Gold(I) Complexes as Anticancer Agents: Ligand Design, Structure-Activity Relationships, and Mechanisms.

Amrin Begum, Navya Pn, Pooran Kumar

|Feb 13, 2026
Auranofin Combination Therapy: A New Frontier in Cancer Treatment.

Diana Laura Guzman-Gomez, Srinivasa Reddy Telukutla, Ruchika Ojha

|Jan 28, 2026
Targeting Monocytes and Their Derivatives in Ovarian Cancer: Opportunities for Innovation in Prognosis and Therapy.

Dharvind Balan, Nirmala Chandralega Kampan, Mohamad Nasir Shafiee

|Dec 30, 2025
HCMV as an Oncomodulatory Virus in Ovarian Cancer: Implications of Viral Strain Heterogeneity, Immunomodulation, and Inflammation on the Tumour Microenvironment and Ovarian Cancer Progression.

Chrissie Giatrakis, Apriliana E R Kartikasari, Thomas A Angelovich

|Nov 05, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Chee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound

Pageof 8

Frequent Collaborators

7 joint publications

Stephens Andrew N

7 joint publications

Jennifer C Boer

6 joint publications

Srinivasa Reddy Telukutla

6 joint publications

Katie Louise Flanagan